This map shows the geographic impact of T Kotake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Kotake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Kotake more than expected).
This network shows the impact of papers produced by T Kotake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Kotake. The network helps show where T Kotake may publish in the future.
Co-authorship network of co-authors of T Kotake
This figure shows the co-authorship network connecting the top 25 collaborators of T Kotake.
A scholar is included among the top collaborators of T Kotake based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with T Kotake. T Kotake is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Yamaguchi, Yasuo, T Toge, T Kinouchi, et al.. (2000). A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.. PubMed. 6(7). 2661–9.25 indexed citations
Akaza, Hideyuki, et al.. (1997). [Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group].. PubMed. 24(1). 77–85.2 indexed citations
9.
Akaza, Hideyuki, Naoto Miyanaga, Tadashi Tsukamoto, et al.. (1997). [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].. PubMed. 24(7). 829–36.5 indexed citations
10.
Meguro, Norio, Yoshitsugu Nakamura, Shinji Saiki, et al.. (1997). Coexistence of renal cell carcinoma and renal angiomyolipoma developing in a kidney: a case report.. PubMed. 43(2). 131–5.8 indexed citations
11.
Maeda, Osamu, Norio Meguro, Shinji Saiki, et al.. (1996). [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].. PubMed. 42(10). 821–7.1 indexed citations
Miki, Takahiro & T Kotake. (1988). [Anti-cancer drug sensitivity test against human testicular cancer xenograft--comparison with clinical results of chemotherapy].. PubMed. 34(11). 1903–9.1 indexed citations
18.
Usami, M, T Kotake, Michiyuki Matsuda, et al.. (1988). [Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)].. PubMed. 34(2). 369–82.2 indexed citations
Usami, M, T Kotake, Michiyuki Matsuda, et al.. (1988). [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].. PubMed. 34(10). 1853–63.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.